Atherosclerosis
Volume 176, Issue 1 , Pages 27-35 , September 2004

Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (−/−) mice

  • Kuang-Yuh Chyu

      Affiliations

    • Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
    • ,
  • Odette S Reyes

      Affiliations

    • Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
    • ,
  • Xiaoning Zhao

      Affiliations

    • Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
    • ,
  • Juliana Yano

      Affiliations

    • Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
    • ,
  • Paul Dimayuga

      Affiliations

    • Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
    • ,
  • Jan Nilsson

      Affiliations

    • Department of Medicine, Lund University, University Hospital MAS, Malmo, Sweden
    • ,
  • Bojan Cercek

      Affiliations

    • Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
    • ,
  • Prediman K Shah

      Affiliations

    • Atherosclerosis Research Center, Division of Cardiology, Department of Medicine and Burns and Allen Research Institute, Cedars-Sinai Medical Center and UCLA School of Medicine, 8700 Beverly Blvd., Los Angeles, CA 90048, USA
    • Corresponding Author InformationCorresponding author. Present address: Room 5347, 8700 Beverly Blvd, Los Angeles, CA 90048, USA. Tel.: +1 310 423 3884; fax: +1 310 423 0144.

Received 14 May 2003 ,Revised 25 December 2003 ,Accepted 8 April 2004.

References 

  1. Horkko S, Binder CJ, Shaw PX, et al.  Immunological responses to oxidized LDL. Free Radic. Biol. Med. 2000;28:1771–1779
  2. Ameli S, Hultgardh-Nilsson A, Regnstrom J, et al.  Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 1996;16:1074–1079
  3. Freigang S, Horkko S, Miller E, Witztum JL, Palinski W. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol. 1998;18:1972–1982
  4. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA. 1995;92:821–825
  5. George J, Afek A, Gilburd B, et al.  Hyperimmunization of apo-E-deflcient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 1998;138:147–152
  6. Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2001;21:108–114
  7. Napoli C, D’Armiento FP, Mancini FP, et al.  Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 1997;100:2680–2690
  8. McGill HC, McMahan CA. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am. J. Cardiol. 1998;82:30T–36T
  9. Tuzcu EM, Kapadia SR, Tutar E, McCarthy PM, et al.  High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation. 2001;103:2705–2710
  10. Romero-Steiner S, Musher DM, Cetron MS, et al.  Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin. Infect. Dis. 1999;29:281–288
  11. Yung RL. Changes in immune function with age. Rheum. Dis. Clin. North Am. 2000;26:455–473
  12. Shah PK, Nilsson J, Kaul S, et al.  Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation. 1998;97:780–785
  13. Lee TS, Yen HC, Pan CC, Chau LY. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 1999;19:734–742
  14. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 1994;14:133–140
  15. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb. 1994;14:141–147
  16. Palinski W, Rosenfeld ME, Yla-Herttuala S, et al.  Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 1989;86:1372–1376
  17. Calara F, Dimayuga P, Niemann A, et al.  An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler.Thromb. Vasc. Biol. 1998;18:884–893
  18. Binder CJ, Chang MK, Shaw PX, et al.  Innate and acquired immunity in atherogenesis. Nat. Med. 2002;8:1218–1226
  19. Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 1996;16:1019–1025
  20. Feng J, Han J, Pearce SF, et al.  Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J. Lipid Res. 2000;41:688–696
  21. Cornicelli JA, Butteiger D, Rated DL, Welch K, Daugherty A. Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages. J. Lipid Res. 2000;41:376–383
  22. Lee YW, Kuhn H, Hennig B, Neish AS, Toborek M. IL-4-induced Oxidative Stress Upregulates VCAM-1 Gene Expression in Human Endothelial Cells. J. Mol. Cell Cardiol. 2001;33:83–94
  23. George J, Shoenfeld Y, Gilburd B, et al.  Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ. Res. 2000;S6:1203–1210
  24. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 2002;109:745–753
  25. King VL, Szilvassy SJ, Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor −/− mice. Arterioscler. Thromb. Vasc. Biol. 2002;22:456–461
  26. Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 2002;22:1892–1898
  27. Lopes-Virella MF, Binzafar N, Rackley S, et al.  The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor. Atherosclerosis. 1997;135:161–170
  28. Huang Y, Jaffa A, Koskinen S, Takei A, Lopes-Virella MF. Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen- activated protein kinase activation in THP-1 macrophages. Arterioscler. Thromb. Vasc. Biol. 1999;19:1600–1607
  29. Shaw PX, Horkko S, Chang MK, et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 2000;105:1731–1740
  30. Shaw PX, Horkko S, Tsimikas S, et al.  Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler. Thromb. Vasc. Biol. 2001;21:1333–1339

PII: S0021-9150(04)00232-1

doi: 10.1016/j.atherosclerosis.2004.04.016

Atherosclerosis
Volume 176, Issue 1 , Pages 27-35 , September 2004

Article Tools

* Image Usage & Resolution